Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
One injection of 68Ga-NOTA-AE105
DRUG
2 trials
Sponsors
Rigshospitalet, Denmark
Conditions
Glioblastoma Multiforme
Neuroendocrine Tumors
Phase 2
uPAR-PET/MRI in Glioblastoma Multiforme
NCT02945826
Rigshospitalet, Denmark
Glioblastoma Multiforme
Start: 2017-01-31
End: 2020-12-31
Target: 35
Updated: 2018-04-10
PET/CT Imaging of uPAR-expression in Patients With Neuroendocrine Tumors Using 68Ga-NOTA-AE105
Completed
NCT03278275
Rigshospitalet, Denmark
Neuroendocrine Tumors
Start: 2017-11-01
End: 2021-07-08
Updated: 2022-06-30
Related Papers
Prospective phase II trial of [<sup>68</sup>Ga]Ga-NOTA-AE105 uPAR-PET/MRI in patients with primary gliomas: Prognostic value and Implications for uPAR-targeted Radionuclide Therapy.
2024-10-29
4 citations